In the recent past, it has repeatedly been reported that CD4 cells play an important role in the immunology of chronic myeloid leukaemia. It was therefore of interest to test their activity in an animal model using bcr-abl-transformed cells. BALB/c mice were four times immunized with a DNA vaccine carrying the bcr-abl fusion gene. Two weeks after the last vaccine dose, the animals were challenged with syngeneic bcr-abl-transformed 12B1 cells which form solid tumors after subcutaneous administration. At the time of challenge, animals were treated with antibodies against the CD8+ T cells or CD4+ T cells. The efficacy of the depletion was monitored and found highly effective. All nonimmunized animals developed tumors. All animals untreated with the antibodies as well as those in which CD8+ T cells had been depleted, were fully protected against the challenge. On the other hand, almost all mice treated with anti-CD4+ antibody developed tumors. These results strongly suggested that the CD4+ T cells acted as effectors in the present system.

Institute of Hematology and Blood Transfusion Department of Experimental Virology U Nemocnice 1 12820 Prague 2 Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc14074400

003      

CZ-PrNML

005      

20191015104626.0

007      

ta

008      

141006s2013 ua f 000 0|eng||

009      

AR

024    7_

$a 10.1155/2013/923107 $2 doi

035    __

$a (PubMed)24348684

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ua

100    1_

$a Petráčková, Martina $u Institute of Hematology and Blood Transfusion, Department of Experimental Virology, U Nemocnice 1, 12820 Prague 2, Czech Republic. $7 xx0086591

245    10

$a Tumor protective activity of CD4+ but not of CD8+ T cells in DNA-vaccinated mice challenged with bcr-abl-transformed cells / $c M. Petráčková, V. Lučanský, V. Vonka,

520    9_

$a In the recent past, it has repeatedly been reported that CD4 cells play an important role in the immunology of chronic myeloid leukaemia. It was therefore of interest to test their activity in an animal model using bcr-abl-transformed cells. BALB/c mice were four times immunized with a DNA vaccine carrying the bcr-abl fusion gene. Two weeks after the last vaccine dose, the animals were challenged with syngeneic bcr-abl-transformed 12B1 cells which form solid tumors after subcutaneous administration. At the time of challenge, animals were treated with antibodies against the CD8+ T cells or CD4+ T cells. The efficacy of the depletion was monitored and found highly effective. All nonimmunized animals developed tumors. All animals untreated with the antibodies as well as those in which CD8+ T cells had been depleted, were fully protected against the challenge. On the other hand, almost all mice treated with anti-CD4+ antibody developed tumors. These results strongly suggested that the CD4+ T cells acted as effectors in the present system.

650    _2

$a zvířata $7 D000818

650    _2

$a antigeny CD95 $x imunologie $x metabolismus $7 D019014

650    _2

$a CD4-pozitivní T-lymfocyty $x imunologie $x metabolismus $7 D015496

650    _2

$a CD8-pozitivní T-lymfocyty $x imunologie $x metabolismus $7 D018414

650    _2

$a protinádorové vakcíny $x genetika $x imunologie $7 D019496

650    _2

$a transformované buněčné linie $7 D002461

650    _2

$a nádorová transformace buněk $x genetika $x imunologie $7 D002471

650    _2

$a modely nemocí na zvířatech $7 D004195

650    _2

$a ligand Fas $x metabolismus $7 D053222

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a bcr-abl fúzové proteiny $x genetika $x imunologie $7 D016044

650    _2

$a histokompatibilita - antigeny třídy II $x imunologie $x metabolismus $7 D000949

650    _2

$a lidé $7 D006801

650    _2

$a imunizace $7 D007114

650    _2

$a lymfocytární deplece $7 D008212

650    _2

$a myši $7 D051379

650    _2

$a nádory $x genetika $x imunologie $x mortalita $x prevence a kontrola $7 D009369

650    _2

$a slezina $x cytologie $x imunologie $7 D013154

650    _2

$a DNA vakcíny $x imunologie $7 D019444

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Lučanský, Vincent $u Institute of Hematology and Blood Transfusion, Department of Experimental Virology, U Nemocnice 1, 12820 Prague 2, Czech Republic. $7 xx0306234

700    1_

$a Vonka, Vladimír, $u Institute of Hematology and Blood Transfusion, Department of Experimental Virology, U Nemocnice 1, 12820 Prague 2, Czech Republic. $d 1930- $7 jk01150642

773    0_

$w MED00013777 $t Clinical & developmental immunology $x 1740-2530 $g Roč. 2013, č. - (2013), s. 923107

856    41

$u https://pubmed.ncbi.nlm.nih.gov/24348684 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20141006 $b ABA008

991    __

$a 20191015105051 $b ABA008

999    __

$a ok $b bmc $g 1042283 $s 873312

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2013 $b 2013 $c - $d 923107 $i 1740-2530 $m Clinical & developmental immunology $n Clin Dev Immunol $x MED00013777

GRA    __

$a NT12363 $p MZ0

LZP    __

$a Pubmed-20141006